From The Cochrane Library, Issue 3, 2003. Oxford: Update Software Ltd. All rights reserved.

Fetal vibroacoustic stimulation for facilitation of tests of fetal wellbeing (Cochrane Review)

Tan KH, Smyth R

ABSTRACT

Order full review
View and/or submit comments
What's new in this issue
Search abstracts
Browse alphabetical list of titles
Browse by Review Group

A substantive amendment to this systematic review was last made on 02 October 2000. Cochrane reviews are regularly checked and updated if necessary.

Background: Acoustic stimulation of the fetus has been suggested to improve the efficiency of antepartum fetal heart rate testing.

Objectives: The objective of this review was to assess the merits or adverse effects of the use of fetal vibroacoustic stimulation in conjunction with tests of fetal wellbeing.

Search strategy: We searched the Cochrane Pregnancy and Childbirth Group trials register. Date of last search: October 2000.

Selection criteria: All published and unpublished randomized controlled trials assessing the merits of the use of fetal vibroacoustic stimulation in conjunction with tests of fetal wellbeing.

Data collection and analysis: Both reviewers independently extracted data and assessed trial quality. Authors of published and unpublished trials were contacted for further information.

Main results: A total of seven trials with a total of 4325 participants were included. Fetal vibroacoustic stimulation reduced the incidence of non-reactive antenatal cardiotocography test (odds ratio (OR) 0.61, 95% confidence interval (CI) 0.49-0.75) and reduced the overall mean cardiotocography testing time (weighted mean difference (WMD) -4.55 minutes, 95% CI -5.96 minutes to -3.14 minutes). Vibroacoustic stimulation compared with mock stimulation evoked significantly more fetal movements when used in conjunction with fetal heart rate testing (OR 0.08, 95% CI 0.06-0.12).

Reviewers' conclusions: Vibroacoustic stimulation offers benefits by decreasing the incidence of non-reactive cardiotocography and reducing the testing time. Further randomized trials should be encouraged to determine not only the optimum intensity, frequency, duration and position of the vibroacoustic stimulation, but also to evaluate the efficacy, predictive reliability, safety and perinatal outcome of these stimuli with cardiotocography and other tests of fetal wellbeing.

Citation: Tan KH, Smyth R. Fetal vibroacoustic stimulation for facilitation of tests of fetal wellbeing (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.



This is an abstract of a regularly updated, systematic review prepared and maintained by the Cochrane Collaboration. The full text of the review is available in The Cochrane Library (ISSN 1464-780X).

The Cochrane Library is designed and produced by Update Software Ltd.

Update Software Ltd, Summertown Pavilion, Middle Way, Oxford OX2 7LG, UK
(Tel:+44 1865 513902; Fax:+44 1865 516918)

File Reference: AB002963.htm